---
id: 194
title: Infections in Cirrhosis
category: special_populations
subcategory: liver_disease
tags: [cirrhosis, SBP, spontaneous-bacterial-peritonitis, norfloxacin, ceftriaxone, ascites]
difficulty: high
---

## Question

How is SBP diagnosed and managed? Use **"Ascites PMN ≥250 → Ceftriaxone + Albumin, Prophylaxis: Norfloxacin/TMP-SMX"** framework.

## Answer

### **Spontaneous Bacterial Peritonitis (SBP):**

**Definition:** Infection of ascitic fluid **without** intra-abdominal source (no perforation, abscess)

**Pathophysiology:**
- **Bacterial translocation** from gut → mesenteric lymph nodes → bloodstream → ascites
- **Impaired immunity** in cirrhosis (complement deficiency, poor opsonization)

### **Diagnosis:**

**Diagnostic Paracentesis (All Patients with Ascites + Infection Signs):**
- **Indications:** Fever, abdominal pain/tenderness, altered mental status (HE), hypotension, GI bleed, renal dysfunction, acidosis

**SBP Criteria:**
- **Ascitic fluid PMN (polymorphonuclear leukocytes) ≥250 cells/μL**
- **Without evidence of intra-abdominal source** (perforated viscus, abscess)

**Culture:**
- **Inoculate blood culture bottles at bedside** (10 mL each into aerobic + anaerobic bottles) - increases yield
- **Monomicrobial** (usually): *E. coli* (most common), *Klebsiella*, *Streptococcus pneumoniae*, other Gram-negatives/streptococci

**Variants:**

| Variant | PMN | Culture | Management |
|---------|-----|---------|------------|
| **Classic SBP** | ≥250 | Positive | Treat |
| **Culture-negative SBP** | ≥250 | Negative | Treat (same as classic) |
| **Bacterascites** | <250 | Positive | Repeat tap in 48h (if symptomatic, treat as SBP) |
| **Secondary peritonitis** | Usually >250 | Polymicrobial | Surgical emergency (perforation, abscess) |

**Distinguish SBP from Secondary Peritonitis:**
- **Secondary peritonitis clues:** Polymicrobial culture, ascitic protein >1 g/dL, glucose <50 mg/dL, LDH >ULN for serum
- **Imaging:** CT abdomen/pelvis (look for abscess, free air, bowel wall thickening)

### **Treatment:**

**Empiric Antibiotics (Start Immediately):**
- **Ceftriaxone 2g IV daily × 5-7 days** (preferred)
- Alternative: **Cefotaxime 2g IV q8h × 5 days**

**Narrow Based on Cultures:**
- **If culture-positive:** Tailor to susceptibilities
- **If culture-negative:** Continue empiric (culture-negative SBP common, ~40%)

**Duration:**
- **5-7 days** (clinical improvement, repeat PMN <250 not required)

**Albumin (Renal Protection):**
- **1.5 g/kg IV within 6h** of diagnosis (max 100g)
- **THEN 1 g/kg IV on day 3**
- **Reduces renal failure, mortality** (type 1 hepatorenal syndrome)

### **Prophylaxis:**

**Primary Prophylaxis (Prevent First Episode):**

**Indications:**
1. **Ascitic protein <1.5 g/dL** + **Cr ≥1.2** OR **BUN ≥25** OR **Na ≤130**
2. **Prior variceal hemorrhage** (GI bleed increases bacterial translocation)
3. **Hospitalized with GI bleed**

**Regimen:**
- **Norfloxacin 400mg PO daily** (first-line, if available)
- **TMP-SMX SS PO daily** (alternative)
- **Ciprofloxacin 500mg PO weekly** (alternative, but less effective)

**Duration:** Long-term (as long as ascites/cirrhosis persists)

**Secondary Prophylaxis (After SBP Episode):**

**Indication:** History of SBP (high recurrence rate, 70% at 1 year)

**Regimen:**
- **Norfloxacin 400mg PO daily** (lifelong)
- **TMP-SMX SS PO daily** (alternative)

### **Complications of SBP:**

**Hepatorenal Syndrome (HRS):**
- **Type 1 HRS:** Rapid renal failure (Cr doubling to >2.5 mg/dL in <2 weeks)
- **Albumin reduces risk** (give with SBP treatment)

**Hepatic Encephalopathy (HE):**
- **Infection precipitates HE** (ammonia production)
- **Treat HE:** Lactulose, rifaximin

**Mortality:**
- **In-hospital mortality:** 20-30%
- **1-year mortality:** 50-70% (poor prognosis)

### **Special Situations:**

**Healthcare-Associated SBP:**
- **Nosocomial infection** (>48h hospitalization)
- **Higher risk of resistant organisms** (ESBL, *Pseudomonas*, enterococci)
- **Empiric:** **Piperacillin-tazobactam 3.375-4.5g IV q6-8h** OR **carbapenem**

**SBP with Renal Dysfunction:**
- **Albumin critical** (1.5 g/kg day 1, 1 g/kg day 3)
- **Avoid nephrotoxic agents** (aminoglycosides, NSAIDs)

## Key Points

### **PMN ≥250 = SBP:**
- **Diagnostic threshold:** Ascitic PMN ≥250 cells/μL
- **Treat immediately** (ceftriaxone 2g daily × 5-7 days)

### **Albumin Reduces Mortality:**
- **1.5 g/kg day 1** (within 6h) + **1 g/kg day 3**
- **Prevents type 1 hepatorenal syndrome**

### **Prophylaxis:**
- **Primary:** Ascitic protein <1.5 g/dL + renal dysfunction OR prior variceal bleed → norfloxacin daily
- **Secondary:** After SBP episode → norfloxacin daily (lifelong)

### **Culture-Negative SBP:**
- **40% of SBP cases**
- **Treat same as culture-positive** (ceftriaxone × 5-7 days)

### **Secondary Peritonitis:**
- **Polymicrobial culture** + **high protein/low glucose/high LDH** → surgical emergency

### **Clinical Pearls:**
- **Ascites PMN ≥250** = SBP → ceftriaxone 2g daily + albumin (1.5 g/kg day 1, 1 g/kg day 3)
- **Prophylaxis:** Ascitic protein <1.5 + renal dysfunction → norfloxacin 400mg daily
- **After SBP:** Lifelong norfloxacin (70% recurrence at 1 year without prophylaxis)
- **Culture-negative SBP:** Common (40%), treat same as culture-positive
- **Albumin critical** (reduces renal failure, mortality)

## Sources

- [AASLD: SBP Guidelines 2024]
- [Hepatology: SBP Management 2024]

## Media

N/A
